News
DIY nerve stimulation effective in episodic migraine
Participants in a new study applied neurostimulation for a continuous 2-hour period within 4 hours of a migraine attack.
News
COVID-19: Greater mortality among psych patients remains a mystery
A diagnosis of a schizophrenia spectrum disorder was associated with an almost threefold increased risk for mortality, compared with bipolar...
News
Lipid levels tied to ALS risk
The findings point to potential future biomarkers in screening for ALS.
News
Optimal antipsychotic dose for schizophrenia relapse identified
“The safest approach is to just to carry on with 5 mg,” which in many cases represents a full dose, said lead author Dr. Stefan Leucht.
News
‘Innovative’ equine therapy helps overcome PTSD symptoms
“I’m very keen on moving this along into a civilian population,” said coinvestigator Dr. Yuval Neria, whose study focused on military veterans.
News
COVID-19 tied to acceleration of Alzheimer’s disease pathology
Patients with Alzheimer’s disease are at threefold higher risk for COVID infection and have a twofold higher risk for death.
News
Can a supplement that mimics the keto diet reduce seizures?
An open-label feasibility study showed that the dietary supplement was well tolerated.
News
Changes in metabolism tied to risk of subsequent dementia
"These metabolites flag early and late pathology and may be relevant as targets for prevention of dementia."
News
Coffee and the brain: ‘Concerning’ new data
High levels of consumption may have adverse long-term effects on the brain.
News
Reducing air pollution is linked to slowed brain aging and lower dementia risk
The findings have implications for individual behaviors as well as public policy.
News
Twofold increased risk for death from COVID-19 in psych patients
“Doctors need to look at these patients the same way they would other high-risk people.”
News
State-of-the-art psych unit designed with recovery in mind
The new unit is designed both architecturally and clinically to deliver 'trauma-informed' care.
News
A less expensive, more convenient treatment option for MS?
If approved by the FDA, ublituximab would become the only glycoengineered anti-CD20 monoclonal antibody for MS.
News
Dose-dependent effect of ‘internet addiction’ and sleep problems
Mechanisms linking internet addiction and sleep disorders are not clear, but the relationship is probably multifactorial and perhaps interrelated...